Capped pyrazinoylguanidine sodium channel blockers

Details Capped pyrazinoylguanidine sodium channel blockers Capped pyrazinoylguanidine sodium channel blockers

2005-08-03

2010-10-05

Wilson, James O (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

active

07807834

ABSTRACT:
The present invention relates to group of pyrazinoylguanidine compounds useful as sodium channel blockers. The compounds may be used to promote promoting hydration of mucosal surfaces.

REFERENCES:
patent: 4894376 (1990-01-01), Morad et al.
patent: 6858614 (2005-02-01), Johnson
patent: 6858615 (2005-02-01), Johnson
patent: 6903105 (2005-06-01), Johnson
patent: 2004/0198744 (2004-10-01), Johnson
patent: 2004/0198745 (2004-10-01), Johnson
patent: 2004/0198746 (2004-10-01), Johnson
patent: 2004/0198747 (2004-10-01), Johnson
patent: 2004/0198748 (2004-10-01), Johnson
patent: 2004/0198749 (2004-10-01), Johnson
patent: 2004/0204424 (2004-10-01), Johnson
patent: 2004/0204425 (2004-10-01), Johnson
patent: 2004/0229884 (2004-11-01), Johnson
patent: 2005/0059676 (2005-03-01), Johnson
patent: 2005/0080091 (2005-04-01), Johnson
patent: 2005/0080092 (2005-04-01), Johnson
patent: 2005/0080093 (2005-04-01), Johnson et al.
patent: 2005/0090505 (2005-04-01), Johnson et al.
patent: 2005/0113388 (2005-05-01), Johnson
patent: 2005/0113389 (2005-05-01), Johnson
patent: 2005/0113390 (2005-05-01), Johnson
patent: WO 03/070182 (2003-08-01), None
patent: WO 03/070182 (2003-08-01), None
patent: WO03070182 (2003-08-01), None
patent: WO 2004/073629 (2004-09-01), None
patent: WO 2005/018644 (2005-03-01), None
patent: WO 2005/044180 (2005-05-01), None
patent: WO 2006/022935 (2006-03-01), None
http://www.biology-online.org/dictionary/Oligosaccharide (last accessed on Mar. 20, 2009).
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Borisy, et. al., Proceedings of the National Academy of Sciences of the United States of America, 100(13) 7977-7982.
Kim E. Barrett, et al., Annu. Rev. Physiol. 2000, 62, pp. 535-572.
http://www.faqs.org/health/topics/96/Bronchodilators.html, last accessed on Nov. 22, 2009.
Kyle, et. al., J. Med. Chem. 2007, 50, 2583-2588.
U.S. Appl. No. 11/261,734, filed Oct. 31, 2005, Johnson.
U.S. Appl. No. 11/960,989, filed Dec. 20, 2007, Johnson, et al.
U.S. Appl. No. 11/950,674, filed Dec. 5, 2007, Johnson, et al.
U.S. Appl. No. 11/835,902, filed Aug. 8, 2007, Johnson, et al.
U.S. Appl. No. 11/573,693, filed Feb. 14, 2007, Johnson.
U.S. Appl. No. 11/573,413, filed Feb. 8, 2007, Johnson.
U.S. Appl. No. 11/573,421, filed Feb. 8, 2007, Johnson.
U.S. Appl. No. 12/049,946, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/049,968, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/049,894, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/050,010, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/049,993, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/050,019, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/061,837, filed Apr. 3, 2008, Johnson, et al.
U.S. Appl. No. 12/061,864, filed Apr. 3, 2008, Johnson, et al.
U.S. Appl. No. 12/098,581, filed Apr. 7, 2008, Johnson.
U.S. Appl. No. 11/695,936, filed Apr. 3, 2007, Johnson.
U.S. Appl. No. 11/696,003, filed Apr. 3, 2007, Johnson.
U.S. Appl. No. 10/920,391, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 10/920,527, filed Aug. 18, 2004, Hopkins.
U.S. Appl. No. 10/532,110, filed Apr. 21, 2005, Johnson.
U.S. Appl. No. 11/138,280, filed May 27, 2005, Johnson, et al.
U.S. Appl. No. 11/131,262, filed May 18, 2005, Johnson, et al.
U.S. Appl. No. 11/545,083, filed Aug. 9, 2005, Johnson.
U.S. Appl. No. 11/211,660, filed Aug. 26, 2005, Johnson, et al.
U.S. Appl. No. 11/211,422, filed aug. 26, 2005, Johnson, et al.
U.S. Appl. No. 11/211,707, filed Aug. 26, 2005, Johnson, et al.
Thomas R. Kleyman, et al., “Distinct epitopes on amiloride. II. Variably restricted epitopes defined by monoclonal anti-amiloride antibodies”, American Journal of Physiology, vol. 260 (2, Pt. 1), 1991, pp. C271-C276.
T. M. Cocks, et al., “Amiloride analogues cause endothelium-dependent relaxation in the canine coronary artery in vitro; possible role of Na+/Ca2+exchange”, British Journal of Pharmacology, vol. 95, 1988, pp. 67-70.
Edward J. Cragoe, et al., “Pyrazine Diuretics. II. N-Amidino-3-amino-5-substituted 6-Halopyrazinecarboxamides”, Journal of Medicinal Chemistry, vol. 10, No. 1, 1967, pp. 66-75.
U.S. Appl. No. 11/852,003, filed Sep. 7, 2007, Johnson, et al.
U.S. Appl. No. 11/851,803, filed Sep. 7, 2007, Johnson, et al.
U.S. Appl. No. 12/249,175, filed Oct. 10, 2008, Boucher, et al.
U.S. Appl. No. 12/304,006, filed Dec. 9, 2008, Johnson, et al.
U.S. Appl. No. 12/304,042, filed Dec. 9, 2008, Johnson.
U.S. Appl. No. 12/304,040, filed Dec. 9, 2008, Johnson.
U.S. Appl. No. 60/495,725, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/495,720, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/495,712, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/602,312, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 60/602,327, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 60/812,091, filed Jun. 9, 2006, Johnson.
U.S. Appl. No. 60/812,077, filed Jun. 9, 2006, Johnson, et al.
U.S. Appl. No. 60/812,078, filed Jun. 9, 2006, Johnson.
U.S. Appl. No. 60/842,669, filed Sep. 7, 2006, Johnson, et al.
U.S. Appl. No. 60/842,963, filed Sep. 8, 2006, Johnson, et al.
U.S. Appl. No. 60/845,171, filed Sep. 18, 2006, Johnson, et al.
U.S. Appl. No. 60/909,818, filed Apr. 3, 2007, Johnson, et al.
U.S. Appl. No. 60/978,887, filed Oct. 10, 2007, Boucher, et al.
U.S. Appl. No. 60/978,874, filed Oct. 10, 2007, Boucher, et al.
U.S. Appl. No. 60/987,663, filed Nov. 13, 2007, Johnson, et al.
U.S. Appl. No. 61/013,387, filed Dec. 13, 2007, Johnson, et al.
U.S. Appl. No. 61/030,313, filed Feb. 21, 2008, Johnson.
U.S. Appl. No. 61/031,466, filed Feb. 26, 2008, Johnson.
U.S. Appl. No. 12/171,814, filed Jul. 11, 2008, Johnson, et al.
U.S. Appl. No. 12/171,867, filed Jul. 11, 2008, Johnson, et al.
U.S. Appl. No. 12/171,897, filed Jul. 11, 2008, Johnson, et al.
U.S. Appl. No. 12/190,022, filed Aug. 12, 2008, Johnson.
U.S. Appl. No. 61/079,989, filed Jul. 11, 2008, Boucher, et al.
U.S. Appl. No. 12/179,353, filed Jul. 24, 2008, Johnson.
U.S. Appl. No. 12/501,654, filed Jul. 13, 2009, Boucher, et al.
U.S. Appl. No. 12/393,252, filed Feb. 26, 2009, Johnson.

Affiliated with

Also associated with

Rating

Capped pyrazinoylguanidine sodium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Capped pyrazinoylguanidine sodium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Capped pyrazinoylguanidine sodium channel blockers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4149730